Is Solid Biosciences LLC (SLDB) overvalued? · rev $8.1M
Solid Biosciences LLC (SLDB) is a biotechnology company listed on US.
This page asks whether Solid Biosciences LLC (SLDB) looks expensive on cached numbers — not a short thesis.
Latest reported SLDB revenue for 2022-12-31 was $8.1M. Net income was -$86.0M. SLDB currently screens at market cap $389.9M.
SLDB currently screens at market cap $389.9M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SLDB 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SLDB stock page for the full model, not this heading.
Not investment advice.